10-QPeriod: Q3 FY2023

AXON ENTERPRISE, INC. Quarterly Report for Q3 Ended Sep 30, 2023

Filed November 7, 2023For Securities:AXON

Summary

Axon Enterprise, Inc. (AXON) reported strong revenue growth in the third quarter and first nine months of 2023, driven by increases in both its TASER and Software and Sensors segments. Net sales for the quarter reached $413.6 million, a 32.7% increase year-over-year, while the nine-month total reached $1.1 billion, up 32.5%. This growth was fueled by robust demand for Axon Evidence and cloud services, Axon Body Cameras, and Axon Fleet Systems, alongside steady performance in TASER devices and cartridges. The company demonstrated improved operational efficiency, with income from operations rising significantly to $55.1 million for the quarter and $112.0 million for the nine months, compared to the prior year periods. While gross margin percentage saw a slight dip due to the ramp-up of new products like TASER 10 and increased costs in certain hardware and professional services, the overall dollar increase in gross margin was substantial. The company also managed its operating expenses effectively, with SG&A and R&D expenses growing at a slower pace than revenue, indicating good cost control as the company scales.

Financial Statements
Beta

Key Highlights

  • 1Revenue increased by 32.7% to $413.6 million in Q3 2023 and by 32.5% to $1.1 billion in the first nine months of 2023, compared to the prior year periods.
  • 2Income from operations significantly improved, reaching $55.1 million in Q3 2023 and $112.0 million for the nine months, up from $32.1 million and $70.7 million, respectively.
  • 3The Software and Sensors segment continued its strong growth trajectory, with net sales increasing by 50.4% in Q3 and 48.2% for the nine months.
  • 4Axon Evidence and cloud services revenue saw substantial increases, growing 55.5% in Q3 and 55.0% for the nine months, reflecting continued adoption of their cloud solutions.
  • 5Despite a slight decrease in gross margin percentage (61.7% in Q3 2023 vs. 62.0% in Q3 2022), gross margin dollars increased significantly due to higher sales volumes.
  • 6The company maintained a strong liquidity position with $406.0 million in cash and cash equivalents as of September 30, 2023.
  • 7A material weakness in internal control over financial reporting related to revenue recognition and deferred revenue was identified and is being remediated; however, the cumulative impact on past financial statements was immaterial.

Frequently Asked Questions